Trinity Pharma, a Waltham company that provides cloud-based data, analytics, and mobile solutions for the life sciences industry, said Tuesday that it has raised $15 million in growth capital.
Health Enterprise Partners, a New York-based private equity firm, led the investment. David Tamburri, a general partner at the firm, will join Trinity’s board of directors.
“Over the last 12 years, Trinity has built a proven business and technology that is solving the increasingly complex challenges that life sciences and health care companies face worldwide,” Tamburri said in a statement. “The rapid change in health care requires real-time analytics to provide value beyond counting pills and with the potential to improve patient outcomes. With a seasoned management team, led by cofounder and CEO Zackary King, we see tremendous opportunity to accelerate Trinity’s growth in support of demand for its cloud-based software.”
The infusion of capital will fuel the expansion of Trinity’s sales and delivery teams and the continued evolution of its core product, AgileM, a cloud-based mobile analytics platform, Trinity said in a press release.
Chris Reidy can be reached at firstname.lastname@example.org.